Sarah A. Robinson
Sarah A. Robinson
PhD Student at University of Oxford
Verified email at
Cited by
Cited by
Ab-Ligity: identifying sequence-dissimilar antibodies that bind to the same epitope
WK Wong, SA Robinson, A Bujotzek, G Georges, AP Lewis, J Shi, ...
MAbs 13 (1), 1873478, 2021
Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodies
SA Robinson, MIJ Raybould, C Schneider, WK Wong, C Marks, ...
PLoS computational biology 17 (12), e1009675, 2021
Bioprocessing automation in cell therapy manufacturing: Outcomes of special interest group automation workshop
O Ball, S Robinson, KIM Bure, DA Brindley, D Mccall
Cytotherapy 20 (4), 592-599, 2018
Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics
R Khetan, R Curtis, CM Deane, JT Hadsund, U Kar, K Krawczyk, ...
MAbs 14 (1), 2020082, 2022
The allosteric modulation of complement C5 by knob domain peptides
A Macpherson, M Laabei, Z Ahdash, MA Graewert, JR Birtley, ...
Elife 10, e63586, 2021
EU market authorisation strategy: lessons from the first 22 ATMP submitted to the EMA
CA Bravery, O Ball, S Robinson
Cell Gene Ther. Insights 5, 759-791, 2019
Epitope profiling of coronavirus-binding antibodies using computational structural modelling
SA Robinson, MIJ Raybould, C Schneider, WK Wong, C Marks, ...
bioRxiv, 2021.04. 12.439478, 2021
Making the grade: untangling the myths of raw materials used for the manufacture of cell-and gene-based medicinal products
CA Bravery, S Robinson, SR Burger
Cell Gene Ther. Insights 4 (3), 207-25, 2018
The changing regulatory landscape for laboratory developed tests
SA Robinson, AR Carter, DA Brindley, MBA MEng
Regulatory Affairs Professionals Society (RAPS), 2021
The system can't perform the operation now. Try again later.
Articles 1–9